US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Is a

Patent

Patent attributes

Patent Applicant

Avidity Biosciences

Current Assignee

Avidity Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119999550

Patent Inventor Names

Rob Burke0

David Sala Cano0

Beatrice Diana Darimont0

Barbora Malecova0

Date of Patent

June 4, 2024

Patent Application Number

180528980

Date Filed

November 4, 2022

Patent Citations

‌

US Patent 7067511 Pyrrolobenzodiazepines

‌

US Patent 7078196 RNA interference mediating small RNA molecules

‌

US Patent 7132519 Releasable nonvolatile mass-label molecules

‌

US Patent 7244724 Pyrrolobenzodiazepines

‌

US Patent 7250496 Bioinformatically detectable group of novel regulatory genes and uses thereof

‌

US Patent 7276497 Cytotoxic agents comprising new maytansinoids

‌

US Patent 7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof

‌

US Patent 7364731 Polypeptide variants

...

Patent Primary Examiner

‌

Aurora M Fontainhas

Patent abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy